Skip to content

PolitiKit

Lobbying by GlaxoSmithKline Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

GlaxoSmithKline Inc.

Meetings this Parliament
2
With MPs
1
Since Nov 2021
2
Active registrations
0

Most recent reported meeting: Nov 25, 2025.

Registrations in effect

GlaxoSmithKline Inc. has no active registration. Organizations must register once paid lobbying passes the legal threshold, and their registration ends when it stops.

Reported meetings

Spreadsheet
  • Reported by Chase Tribble · Consultant

    • Fabien Lengelle · Director General, Immigration, Refugees and Citizenship Canada (IRCC)
    • Jessica Halverson · Director, Immigration, Refugees and Citizenship Canada (IRCC)
    • Elaine Chong · Director, Immigration, Refugees and Citizenship Canada (IRCC)
    Antimicrobial Resistance (AMR) - Identification of the need for a multi-sectoral stakeholder working group to pursue joint goals under a Pan-Canadian AMR strategy and to strengthen Canada's end-to-end research capacity in AMR. Read more

    Official report

  • Reported by Chase Tribble · Consultant

    Antimicrobial Resistance (AMR) - Identification of the need for a multi-sectoral stakeholder working group to pursue joint goals under a Pan-Canadian AMR strategy and to strengthen Canada's end-to-end research capacity in AMR. Read more

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.